British Journal of Cancer - Table of Contents alert Volume 112 Issue 6

If you are unable to see the message below, click here to view.

TABLE OF CONTENTS Volume 112, Issue 6 (957-1140) Published online 17 March 2015 In this issue Minireview Clinical Studies Translational Therapeutics Molecular Diagnostics Genetics and Genomics Also new today Advance online publication Digital Edition Sign up for e-alerts Recommend to your library Web feed Subscribe Minireview Top Mitochondrial apoptosis: killing cancer using the enemy within J Lopez and S W G Tait Br J Cancer 2015 112: 957-962; advance online publication, March 5, 2015; 10.1038/bjc.2015.85 Abstract | Full Text Clinical Studies Top Correlation of extended RAS and PIK3CA gene mutation status with outcomes from the phase III AGITG MAX STUDY involving capecitabine alone or in combination with bevacizumab plus or minus mitomycin C in advanced colorectal cancer T J Price, M A Bruhn, C K Lee, J E Hardingham, A R Townsend, K P Mann, J Simes, A Weickhardt, J W Wrin, K Wilson, V Gebski, G Van Hazel, B Robinson, D Cunningham and N C Tebbutt Br J Cancer 2015 112: 963-970; advance online publication, March 5, 2015; 10.1038/bjc.2015.37 Abstract | Full Text Assessing the benefit–risk of new treatments using generalised pairwise comparisons: the case of erlotinib in pancreatic cancer J Péron, P Roy, K Ding, W R Parulekar, L Roche and M Buyse Br J Cancer 2015 112: 971-976; advance online publication, February 17, 2015; 10.1038/bjc.2015.55 Abstract | Full Text Complications following surgery with or without radiotherapy or radiotherapy alone for prostate cancer C J D Wallis, P Cheung, S Herschorn, R Saskin, J Su, L H Klotz, G S Kulkarni, Y Lee, R T Kodama, S A Narod and R K Nam Br J Cancer 2015 112: 977-982; advance online publication, February 17, 2015; 10.1038/bjc.2015.54 Abstract | Full Text An evaluation of the prognostic model PREDICT using the POSH cohort of women aged 40 years at breast cancer diagnosis T Maishman, E Copson, L Stanton, S Gerty, E Dicks, L Durcan, G C Wishart, P Pharoah, POSH Steering Group and D Eccles Br J Cancer 2015 112: 983-991; advance online publication, February 12, 2015; 10.1038/bjc.2015.57 Abstract | Full Text A preoperative nomogram to predict the risk of synchronous distant metastases at diagnosis of primary breast cancer C Boutros, C Mazouni, F Lerebours, D Stevens, X Lei, A M Gonzalez-Angulo and S Delaloge Br J Cancer 2015 112: 992-997; advance online publication, February 10, 2015; 10.1038/bjc.2015.34 Abstract | Full Text A multi-centre randomised trial comparing ultrasound vs mammography for screening breast cancer in high-risk Chinese women S Shen, Y Zhou, Y Xu, B Zhang, X Duan, R Huang, B Li, Y Shi, Z Shao, H Liao, J Jiang, N Shen, J Zhang, C Yu, H Jiang, S Li, S Han, J Ma and Q Sun Br J Cancer 2015 112: 998-1004; advance online publication, February 10, 2015; 10.1038/bjc.2015.33 Abstract | Full Text Text-message reminders increase uptake of routine breast screening appointments: a randomised controlled trial in a hard-to-reach population R S Kerrison, H Shukla, D Cunningham, O Oyebode and E Friedman Br J Cancer 2015 112: 1005-1010; advance online publication, February 10, 2015; 10.1038/bjc.2015.36 Abstract | Full Text Incidence and relevance of QTc-interval prolongation caused by tyrosine kinase inhibitors J S L Kloth, A Pagani, M C Verboom, A Malovini, C Napolitano, W H J Kruit, S Sleijfer, N Steeghs, A Zambelli and R H J Mathijssen Br J Cancer 2015 112: 1011-1016; advance online publication, March 5, 2015; 10.1038/bjc.2015.82 Abstract | Full Text Childhood acute lymphoblastic leukaemia and indicators of early immune stimulation: the Estelle study (SFCE) R Ajrouche, J Rudant, L Orsi, A Petit, A Baruchel, A Lambilliotte, M Gambart, G Michel, Y Bertrand, S Ducassou, V Gandemer, C Paillard, L Saumet, N Blin, D Hémon and J Clavel Br J Cancer 2015 112: 1017-1026; advance online publication, February 12, 2015; 10.1038/bjc.2015.53 Abstract | Full Text Translational Therapeutics Top Prognostic and predictive value of immunological parameters for chemoradioimmunotherapy in patients with pancreatic adenocarcinoma S Karakhanova, E Ryschich, B Mosl, S Harig, D Jäger, J Schmidt, W Hartwig, J Werner and A V Bazhin Br J Cancer 2015 112: 1027-1036; advance online publication, March 5, 2015; 10.1038/bjc.2015.72 Abstract | Full Text Development and economic trends in cancer therapeutic drugs: a 5-year update 2010–2014 P Savage and S Mahmoud Br J Cancer 2015 112: 1037-1041; advance online publication, February 10, 2015; 10.1038/bjc.2015.56 Abstract | Full Text Novel therapeutic strategy targeting the Hedgehog signalling and mTOR pathways in biliary tract cancer M Zuo, A Rashid, C Churi, J-N Vauthey, P Chang, Y Li, M-C Hung, D Li and M Javle Br J Cancer 2015 112: 1042-1051; advance online publication, March 5, 2015; 10.1038/bjc.2014.625 Abstract | Full Text Molecular Diagnostics Top Protein shedding in urothelial bladder cancer: prognostic implications of soluble urinary EGFR and EpCAM R T Bryan, H L Regan, S J Pirrie, A J Devall, K K Cheng, M P Zeegers, N D James, M A Knowles and D G Ward Br J Cancer 2015 112: 1052-1058; advance online publication, February 26, 2015; 10.1038/bjc.2015.21 Abstract | Full Text ATM has a major role in the double-strand break repair pathway dysregulation in sporadic breast carcinomas and is an independent prognostic marker at both mRNA and protein levels S Rondeau, S Vacher, L De Koning, A Briaux, A Schnitzler, W Chemlali, C Callens, R Lidereau and I Bièche Br J Cancer 2015 112: 1059-1066; advance online publication, March 5, 2015; 10.1038/bjc.2015.60 Abstract | Full Text Epithelial-to-mesenchymal transition (EMT) induced by inflammatory priming elicits mesenchymal stromal cell-like immune-modulatory properties in cancer cells M Ricciardi, M Zanotto, G Malpeli, G Bassi, O Perbellini, M Chilosi, F Bifari and M Krampera Br J Cancer 2015 112: 1067-1075; advance online publication, February 10, 2015; 10.1038/bjc.2015.29 Abstract | Full Text hERG1 channels drive tumour malignancy and may serve as prognostic factor in pancreatic ductal adenocarcinoma E Lastraioli, G Perrone, A Sette, A Fiore, O Crociani, S Manoli, M D'Amico, M Masselli, J Iorio, M Callea, D Borzomati, G Nappo, F Bartolozzi, D Santini, L Bencini, M Farsi, L Boni, F Di Costanzo, A Schwab, A Onetti Muda, R Coppola and A Arcangeli Br J Cancer 2015 112: 1076-1087; advance online publication, February 26, 2015; 10.1038/bjc.2015.28 Abstract | Full Text Cytokine profile and prognostic significance of high neutrophil-lymphocyte ratio in colorectal cancer Z-Y Chen, K Raghav, C H Lieu, Z-Q Jiang, C Eng, J-N Vauthey, G J Chang, W Qiao, J Morris, D Hong, P Hoff, H Tran, D G Menter, J Heymach, M Overman and S Kopetz Br J Cancer 2015 112: 1088-1097; advance online publication, February 17, 2015; 10.1038/bjc.2015.61 Abstract | Full Text Frequency and prognostic significance of p16INK4A protein overexpression and transcriptionally active human papillomavirus infection in laryngeal squamous cell carcinoma R J Young, D Urban, C Angel, J Corry, B Lyons, N Vallance, S Kleid, T A Iseli, B Solomon and D Rischin Br J Cancer 2015 112: 1098-1104; advance online publication, February 17, 2015; 10.1038/bjc.2015.59 Abstract | Full Text DNA hypermethylation analysis in sputum for the diagnosis of lung cancer: training validation set approach A J Hubers, D A M Heideman, S A Burgers, G J M Herder, P J Sterk, R J Rhodius, H J Smit, F Krouwels, A Welling, B I Witte, S Duin, R Koning, E F I Comans, R D M Steenbergen, P E Postmus, G A Meijer, P J F Snijders, E F Smit and E Thunnissen Br J Cancer 2015 112: 1105-1113; advance online publication, February 26, 2015; 10.1038/bjc.2014.636 Abstract | Full Text Genetics and Genomics Top Truncating mutations of PPM1D are found in blood DNA samples of lung cancer patients A Zajkowicz, D Butkiewicz, A Drosik, M Giglok, R Suwiński and M Rusin Br J Cancer 2015 112: 1114-1120; advance online publication, March 5, 2015; 10.1038/bjc.2015.79 Abstract | Full Text A high incidence of WT1 abnormality in bilateral Wilms tumours in Japan, and the penetrance rates in children with WT1 germline mutation Y Kaneko, H Okita, M Haruta, Y Arai, T Oue, Y Tanaka, H Horie, S Hinotsu, T Koshinaga, A Yoneda, Y Ohtsuka, T Taguchi and M Fukuzawa Br J Cancer 2015 112: 1121-1133; advance online publication, February 17, 2015; 10.1038/bjc.2015.13 Abstract | Full Text Mitochondrial dysfunction and risk of cancer M Lund, M Melbye, L J Diaz, M Duno, J Wohlfahrt and J Vissing Br J Cancer 2015 112: 1134-1140; advance online publication, March 5, 2015; 10.1038/bjc.2015.66 Abstract | Full Text Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to British Journal of Cancer. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2015 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.